Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

ARS Pharmaceuticals (SPRY) Asset Utilization Ratio: 2023-2025

Historic Asset Utilization Ratio for ARS Pharmaceuticals (SPRY) over the last 2 years, with Sep 2025 value amounting to 0.42.

  • ARS Pharmaceuticals' Asset Utilization Ratio rose 3419.90% to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42, marking a year-over-year increase of 3419.90%. This contributed to the annual value of 0.31 for FY2024, which is 261608.64% up from last year.
  • According to the latest figures from Q3 2025, ARS Pharmaceuticals' Asset Utilization Ratio is 0.42, which was up 18.67% from 0.35 recorded in Q2 2025.
  • In the past 5 years, ARS Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.42 in Q3 2025 and a low of 0.00 during Q2 2023.
  • For the 3-year period, ARS Pharmaceuticals' Asset Utilization Ratio averaged around 0.17, with its median value being 0.15 (2024).
  • Data for ARS Pharmaceuticals' Asset Utilization Ratio shows a peak YoY soared of 10,861.32% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows ARS Pharmaceuticals' Asset Utilization Ratio stood at 0.00 in 2023, then grew by 24.10% to 0.31 in 2024, then soared by 3,419.90% to 0.42 in 2025.
  • Its last three reported values are 0.42 in Q3 2025, 0.35 for Q2 2025, and 0.29 during Q1 2025.